Status:
COMPLETED
The Avoiding Diabetes Thru Action Plan Targeting Pilot Randomized Control Trial
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Prediabetes
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The goal of this randomized control trial is to study the impact of an electronic health record embedded tool's ability to facilitate shared provider-patient goal setting to promote lifestyle behavior...
Detailed Description
The ADAPT (Avoiding Diabetes Thru Action Plan Targeting) trial is an innovative study that leverages persuasive technology to enhance the lifestyle behavior change counseling efficacy of primary care ...
Eligibility Criteria
Inclusion
- prediabetes
Exclusion
- age\<18
- diabetes
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01473654
Start Date
November 1 2011
End Date
April 1 2014
Last Update
August 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Medical Center
New York, New York, United States, 10029